↓ Skip to main content

A new platform for post-marketing surveillance and real-world evidence data collection for substance-based medical devices

Overview of attention for article published in Frontiers in Drug Safety and Regulation, December 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A new platform for post-marketing surveillance and real-world evidence data collection for substance-based medical devices
Published in
Frontiers in Drug Safety and Regulation, December 2022
DOI 10.3389/fdsfr.2022.992359
Authors

Roberto Cioeta, Andrea Cossu, Emiliano Giovagnoni, Marta Rigoni, Paola Muti

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 33%
Researcher 1 33%
Unknown 1 33%
Readers by discipline Count As %
Nursing and Health Professions 1 33%
Engineering 1 33%
Unknown 1 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 December 2022.
All research outputs
#14,567,186
of 23,332,901 outputs
Outputs from Frontiers in Drug Safety and Regulation
#6
of 28 outputs
Outputs of similar age
#198,825
of 439,782 outputs
Outputs of similar age from Frontiers in Drug Safety and Regulation
#3
of 10 outputs
Altmetric has tracked 23,332,901 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 28 research outputs from this source. They receive a mean Attention Score of 1.5. This one scored the same or higher as 22 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,782 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.